596
Views
47
CrossRef citations to date
0
Altmetric
Research Article

Synthesis of a novel series of bispyridinium compounds bearing a xylene linker and evaluation of their reactivation activity against chlorpyrifos-inhibited acetylcholinesterase

, , , &
Pages 409-415 | Received 27 Mar 2005, Accepted 21 Apr 2005, Published online: 04 Oct 2008

Figures & data

Scheme 1 Symmetrical bisquaternary xylene-linked compounds.

Scheme 1 Symmetrical bisquaternary xylene-linked compounds.

Scheme 2 AChE inhibited by chlorpyrifos.

Scheme 2 AChE inhibited by chlorpyrifos.

Scheme 3 Synthesis of symmetric bisquaternary compounds.

Scheme 3 Synthesis of symmetric bisquaternary compounds.

Scheme 4 Synthesis of 2,2′-bis(hydroxyiminomethyl)-1,1′-(1,3-phenylenedimethyl)-bispyridinium dibromide.

Scheme 4 Synthesis of 2,2′-bis(hydroxyiminomethyl)-1,1′-(1,3-phenylenedimethyl)-bispyridinium dibromide.

Table I.  Reactivation potencies (%)a of tested oximes. Time of inhibition by chlorpyrifos –30 min; time of reactivation by AChE reactivators –10 min; pH 8; temperature 25°C.

Figure 1 Efficacy of tested oximes in reactivation of chlorpyrifos-inhibited AChE.

Figure 1 Efficacy of tested oximes in reactivation of chlorpyrifos-inhibited AChE.

Scheme 5 Lengths and angles of linking chains in 6, 7 and 8.

Scheme 5 Lengths and angles of linking chains in 6, 7 and 8.

Scheme 6 Bell-shaped curve of reactivation process.

Scheme 6 Bell-shaped curve of reactivation process.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.